u/gallbladder_gary

The confident tone is doing a lot of work that the evidence is not.

Gallstones with rapid weight loss are common enough that it should be part of the standard briefing and it almost never is. Rapid loss changes bile composition; the mechanism is not mysterious and the incidence is not trivial.

Mine came out at month 7 and I would still do the whole thing again. But I would have liked to know it was on the list.

The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.

Not to be pedantic but batch and related substances are being used interchangeably and they are not interchangeable in real life.

Did they tell you their API source or dodge the question?

reimbursement costs in New Zealand this month

The confident tone is doing a lot of work that the evidence is not.

503B compounding is different from 503A, different rules, different legality

Cosigning. The batch number is load-bearing information.

Strongly agree. Pricing is local.

state board rules differ, say which state

regulatory claims need a citation to the actual rule, not interpretation

PDF metadata is checkable in fifteen seconds

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.

the 503A/503B distinction is load-bearing, do not blur it

Adding to this: state board is doing more work than the comment implies.

This is the correct framing. The COA structure matters as much as the number.

503B compounding is different from 503A, different rules, different legality

EMA and national agency claims need citation

Not convinced. The evidence does not support that reading.

purity and net content are two different numbers, same vial

Disagree on that part. 98.4% and 98.3% on the same vial is normal.

axis labels included, always

Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.